omparison the effect of Azelastine spary with budesonide spary in patient with allergic rhinits

Comparison the effect of Azelastine spary with budesonide spary in patient with allergic rhinits that admitted to khatam alanbia hospital in Zahedan in2017

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170806035536N2

Enrollment

Registered

2018-04-18

Start date

2017-08-23

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Other seasonal allergic rhinitis

Interventions

Intervention 1: Intervention group includes volunteers who received azalestin spray. Intervention 2: Intervention group: volunteers who received budesonide spray. Intervention 3: Control group: contro

Eligibility

Sex/Gender

All

Age

5 Years to 90 Years

Inclusion criteria

Inclusion criteria: the absence of patients with non-allergic rhinitis pregnant women those with acute or chronic upper respiratory infections asthmatic patients adenoid hypertrophia

Exclusion criteria

Exclusion criteria: those who have been ill during the study for any reason Did not complete the administration of the prescriptive or incomplete treatment cases of seasonal allergic rhinitis patients exposed to inhaled chemicals

Design outcomes

Primary

Measure	Time frame
Recovery situation. Timepoint: 30 days after the first visit. Method of measurement: The symptoms of the disease that the patient is referring to include nasal congestion, itching of the eyes, and lips.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Reza Ghariby

Zahedan University of Medical Sciences

khatamhospital_zah@yahoo.com+98 54 3322 0501

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026